| Ident. | Authors (with country if any) | Title |
|---|
| 000029 (2017) |
Daryl J. Wile [Canada] ; Pankaj A. Agarwal [Inde] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Katherine Dinelle [Canada] ; Elham Shahinfard [Canada] ; Nasim Vafai [Canada] ; Kazuko Hasegawa [Japon] ; Jing Zhang [États-Unis] ; Jessamyn Mckenzie [Canada] ; Nicole Neilson [Canada] ; Audrey Strongosky [États-Unis] ; Ryan J. Uitti [États-Unis] ; Mark Guttman [Canada] ; Cyrus P. Zabetian [États-Unis] ; Yu-Shin Ding [États-Unis] ; Mike Adam [Canada] ; Jan Aasly [Norvège] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A Jon Stoessl [Canada] | Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. |
| 000033 (2017) |
Lei Xing [Canada] ; Maddie J. Venables [Canada] ; Vance L. Trudeau [Canada] | Role of aromatase and radial glial cells in neurotoxin-induced dopamine neuron degeneration and regeneration. |
| 000066 (2017) |
Kelly M. Lohr [États-Unis] ; Shababa T. Masoud [Canada] ; Ali Salahpour [Canada] ; Gary W. Miller [États-Unis] | Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. |
| 000116 (2017) |
Stephen J. Kish [Canada] ; Isabelle Boileau [Canada] ; Russell C. Callaghan [Canada] ; Junchao Tong [Canada] | Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence. |
| 000141 (2016) |
Nicolas Morin ; Marc Morissette ; Laurent Grégoire ; Thérèse Di Paolo | mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias |
| 000199 (2016) |
Panojot Bifsha [Canada] ; Aurelio Balsalobre [Canada] ; Jacques Drouin [Canada] | Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons. |
| 000207 (2016) |
Kaviraja Udupa [Canada] ; Robert Chen [Canada] | Role of dopamine in motor cortex plasticity in Parkinson's disease. |
| 000243 (2016) |
Edith Miville-Godbout [Canada] ; Mélanie Bourque [Canada] ; Marc Morissette [Canada] ; Sara Al-Sweidi [Canada] ; Tara Smith [Canada] ; Asuka Mochizuki [Canada, Japon] ; Vijitha Senanayake [Canada] ; Dushmanthi Jayasinghe [Canada] ; Li Wang [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice |
| 000314 (2016) |
F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada] | Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources. |
| 000379 (2016) |
Lucia Ricciardi [Royaume-Uni] ; Kristy J. Espay [États-Unis] ; Robert Krikorian [États-Unis] ; Alfonso Fasano [Canada] ; Alberto J. Espay [États-Unis] | Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease. |
| 000380 (2016) |
Mario Masellis [Canada] ; Shannon Collinson [Canada] ; Natalie Freeman [Canada] ; Maria Tampakeras [Canada] ; Joseph Levy [Israël] ; Amir Tchelet [Israël] ; Eli Eyal [Israël] ; Elijahu Berkovich [Israël] ; Rom E. Eliaz [Israël] ; Victor Abler [Israël] ; Iris Grossman [Israël] ; Cheryl Fitzer-Attas [Israël] ; Arun Tiwari [Canada] ; Michael R. Hayden [Israël] ; James L. Kennedy [Canada] ; Anthony E. Lang [Canada] ; Jo Knight [Royaume-Uni] | Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study. |
| 000429 (2016) |
Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman | Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques. |
| 000454 (2016) |
Dimitri Ryczko [Canada] ; Jackson J. Cone ; Michael H. Alpert ; Laurent Goetz [Canada] ; François Auclair [Canada] ; Catherine Dubé [Canada] ; Martin Parent [Canada] ; Mitchell F. Roitman ; Simon Alford ; Réjean Dubuc [Canada] | A descending dopamine pathway conserved from basal vertebrates to mammals |
| 000470 (2015) |
Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. |
| 000524 (2015) |
Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie] | Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease. |
| 000536 (2015) |
Philippe Huot [Canada] ; William D. Hutchison [Canada] | Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia. |
| 000542 (2015) |
Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada] | Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies. |
| 000583 (2015) |
Johanna M. Jarcho [États-Unis] ; Natasha A. Feier [États-Unis, Canada] ; Jennifer S. Labus [États-Unis] ; Bruce Naliboff [États-Unis] ; Suzanne R. Smith [États-Unis] ; Jui-Yang Hong [États-Unis] ; Luana Colloca [États-Unis] ; Kirsten Tillisch [États-Unis] ; Mark A. Mandelkern [États-Unis] ; Emeran A. Mayer [États-Unis] ; Edythe D. London [États-Unis] | Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response |
| 000601 (2015) |
Philip Seeman [Canada] | Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors. |
| 000665 (2015) |
Dayne A. Beccano-Kelly ; Mattia Volta ; Lise N. Munsie ; Sarah A. Paschall ; Igor Tatarnikov ; Kimberley Co ; Patrick Chou ; Li-Ping Cao ; Sabrina Bergeron ; Emma Mitchell ; Heather Han ; Heather L. Melrose [États-Unis] ; Lucia Tapia ; Lynn A. Raymond [Canada] ; Matthew J. Farrer ; Austen J. Milnerwood [Canada] | LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory. |
| 000709 (2015) |
Emily M. Rocha [États-Unis] ; Gaynor A. Smith [États-Unis] ; Eric Park [États-Unis] ; Hongmei Cao [États-Unis] ; Eilish Brown [États-Unis] ; Melissa A. Hayes [États-Unis] ; Jonathan Beagan [États-Unis] ; Jesse R. Mclean [États-Unis] ; Sarah C. Izen [États-Unis] ; Eduardo Perez-Torres [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis] | Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. |
| 000734 (2015) |
Anne Almey [Canada] ; Teresa A. Milner [États-Unis] ; Wayne G. Brake [Canada] | Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females |
| 000739 (2015) |
Consiglia Pacelli [Canada] ; Nicolas Giguère [Canada] ; Marie-Josée Bourque [Canada] ; Martin Lévesque [Canada] ; Ruth S. Slack [Canada] ; Louis-Éric Trudeau [Canada] | Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. |
| 000751 (2015) |
Fang Ba [Canada] ; W R Wayne Martin [Canada] | Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. |
| 000752 (2015) |
Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie] | Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion. |
| 000753 (2015) |
Lei Xing ; Heather Mcdonald ; Dillon F. Da Fonte ; Juan M. Gutierrez-Villagomez ; Vance L. Trudeau | Dopamine D1 receptor activation regulates the expression of the estrogen synthesis gene aromatase B in radial glial cells |
| 000782 (2015) |
Stéphanie De Gois [France, Canada] ; Patrick Slama [France] ; Nicolas Pietrancosta [France] ; Amaia M. Erdozain [France] ; Franck Louis [France] ; Caroline Bouvrais-Veret [France] ; Laurent Daviet [France] ; Bruno Giros [France, Canada] | Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane* |
| 000798 (2015) |
Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Igor Tatarnikov [Canada] ; Patrick Chou [Canada] ; Sabrina Bergeron [Canada] ; Emma Mitchell [Canada] ; Roscoe Lim [Canada] ; Jaskaran Khinda [Canada] ; Alejandro Lloret [États-Unis] ; C Frank Bennett [États-Unis] ; Carmela Paradiso [Italie] ; Michele Morari [Italie] ; Matthew J. Farrer [Canada] ; Austen J. Milnerwood [Canada] | Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release. |
| 000827 (2015) |
María Sierra [Espagne] ; Sébastien Carnicella [France] ; Antonio P. Strafella [Canada] ; Amélie Bichon [France] ; Eugénie Lhommée [France] ; Anna Castrioto [France] ; Stephan Chabardes [France] ; Stéphane Thobois [France] ; Paul Krack [France] | Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors. |
| 000851 (2015) |
Beryl Luk [Canada] ; Mohinuddin Mohammed [Canada] ; Fang Liu [Canada] ; Frank J. S. Lee [Canada] | A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake |
| 000875 (2014) |
Gonzalo Sanchez [Canada] ; Rafael K. Varaschin [Canada] ; Hansruedi Büeler [République populaire de Chine] ; Paul C. Marcogliese [Canada] ; David S. Park [Canada] ; Louis-Eric Trudeau [Canada] | Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice |
| 000877 (2014) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada] | UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset. |
| 000892 (2014) |
Crystal A. Clark ; Alain Dagher | The role of dopamine in risk taking: a specific look at Parkinson’s disease and gambling |
| 000909 (2014) |
Carlos Cepeda [États-Unis] ; Kerry P. S. Murphy [Royaume-Uni] ; Martin Parent [Canada] ; Michael S. Levine [États-Unis] | The Role of Dopamine in Huntington’s Disease |
| 000920 (2014) |
Vincent A. Jourdain [Canada] ; Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Thérèse Di Paolo [Canada] | Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys. |
| 000934 (2014) |
Julio Cesar Aguila [États-Unis] ; Alexandra Blak [États-Unis] ; Joris Van Arensbergen [États-Unis] ; Amaia Sousa [États-Unis] ; Nerea Vázquez [États-Unis] ; Ariane Aduriz [États-Unis] ; Mayela Gayosso [États-Unis] ; Maria Paz Lopez Mato [États-Unis] ; Rakel Lopez De Maturana [États-Unis] ; Eva Hedlund [États-Unis] ; Kai-Christian Sonntag [États-Unis] ; Rosario Sanchez-Pernaute | Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells. |
| 000936 (2014) |
Leigh Christopher [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Barbara Segura [Canada, Espagne] ; Isabelle Boileau [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Pablo Rusjan [Canada] ; Antonio P. Strafella [Canada] | Salience Network and Parahippocampal Dopamine Dysfunction in Memory-Impaired Parkinson Disease |
| 000941 (2014) |
Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada] | Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. |
| 000981 (2014) |
Craig J. Hudson [Canada] ; Philip Seeman [Canada] ; Mary V. Seeman [Canada] | Parkinson's Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response |
| 000990 (2014) |
Kristian Thorlund [Canada, États-Unis] ; Ping Wu [Canada] ; Eric Druyts [Canada] ; Shawn Eapen [Canada] ; Edward J. Mills [États-Unis, Canada] | Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis |
| 000A06 (2014) |
Antonio Cerasa [Italie] ; Alfonso Fasano [Canada] ; Francesca Morgante [Italie] ; Giacomo Koch [Italie] ; Aldo Quattrone [Italie] | Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology |
| 000A10 (2014) |
Penelope J. Hallett [États-Unis] ; Oliver Cooper [États-Unis] ; Damaso Sadi [Canada] ; Harold Robertson [Canada] ; Ivar Mendez [Canada] ; Ole Isacson [États-Unis] | Long-term dopamine transporter expression and normal cellular distribution of mitochondria in dopaminergic neuron transplants in Parkinson’s disease patients |
| 000A22 (2014) |
Christian Pifl [Autriche] ; Alex Rajput [Canada] ; Harald Reither [Autriche] ; Javier Blesa ; Carmen Cavada [Espagne] ; José A. Obeso ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Autriche] | Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. |
| 000A34 (2014) |
Kelly M. Lohr ; Alison I. Bernstein ; Kristen A. Stout ; Amy R. Dunn ; Carlos R. Lazo ; Shawn P. Alter ; Minzheng Wang ; Yingjie Li ; Xueliang Fan ; Ellen J. Hess ; Hong Yi ; Laura M. Vecchio [Canada] ; David S. Goldstein ; Thomas S. Guillot ; Ali Salahpour [Canada] ; Gary W. Miller | Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo |
| 000A35 (2014) |
St Masoud [Canada] ; Lm Vecchio [Canada] ; Y. Bergeron ; Mm Hossain [États-Unis] ; Lt Nguyen [Canada] ; Mk Bermejo [Canada] ; B. Kile [États-Unis] ; Td Sotnikova [Italie, Russie] ; Wb Siesser [États-Unis] ; Rr Gainetdinov [Italie, Russie] ; Rm Wightman [États-Unis] ; Mg Caron [États-Unis] ; Jr Richardson [États-Unis] ; Gw Miller [États-Unis] ; Aj Ramsey [Canada] ; M. Cyr ; A. Salahpour [Canada] | Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and L-DOPA reversible motor deficits |
| 000A45 (2014) |
Franziska Maier [Allemagne] ; Josuah Merkl [Allemagne] ; Anna L. Ellereit [Allemagne] ; Catharine J. Lewis [Allemagne] ; Carsten Eggers [Allemagne] ; David J. Pedrosa [Allemagne] ; Elke Kalbe [Allemagne] ; Jens Kuhn [Allemagne] ; Thomas D. Meyer [Royaume-Uni] ; Mateusz Zurowski [Canada] ; Lars Timmermann [Allemagne] | Hypomania and mania related to dopamine replacement therapy in Parkinson's disease. |
| 000A87 (2014) |
Nicolaas I. Bohnen [Canada] ; W R Wayne Martin [Canada] | Dopamine-dependent functional connectivity in Parkinson disease: a resting-state diagnosis? |
| 000A88 (2014) |
Claudine Habak [Canada] ; Anne Noreau [Canada] ; Atsuko Nagano-Saito [Canada] ; Beatriz Mejía-Constaín [Canada] ; Clotilde Degroot [Canada] ; Antonio P. Strafella [Canada] ; Sylvain Chouinard [Canada] ; Anne-Louise Lafontaine [Canada] ; Guy A. Rouleau [Canada] ; Oury Monchi [Canada] | Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson’s disease |
| 000A89 (2014) |
Jean-Martin Beaulieu [Canada] ; Stefano Espinoza [Italie] ; Raul R. Gainetdinov [Italie, Russie] | Dopamine receptors – IUPHAR Review 13 |
| 000A90 (2014) |
Jay G. Hosking [Canada] ; Stan B. Floresco [Canada] ; Catharine A. Winstanley [Canada] | Dopamine Antagonism Decreases Willingness to Expend Physical, But Not Cognitive, Effort: A Comparison of Two Rodent Cost/Benefit Decision-Making Tasks |
| 000B11 (2014) |
A Jon Stoessl [Canada] ; Glenda M. Halliday | DAT-SPECT diagnoses dopamine depletion, but not PD. |
